Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-22

Clinical Trial Update: Genotype Based Personalized Prescription of Nevirapine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating genotype-based personalized prescribing of nevirapine has completed, examining nevirapine-induced rash and hepatitis in HIV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

Sponsor: Surakameth Mahasirimongkol | Conditions: Nevirapine Induced Rash, Nevirapine Induced Hepatitis | Phase 4 | Status: COMPLETED